U.S. FDA approves Celltrion’s STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)
Share this Story STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic…
Read MoreShare this Story STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic…
Read MoreShare this Story – ASEAN Ceramics & Stone 2024 closes with an increase of 65% in visitorship, with unique buyers…
Read MoreShare this Story eMemory’s Michael Ho discusses how the company is addressing the memory and security challenges in high-performance computing…
Read MoreShare this Story WASHINGTON, Dec. 17, 2024 /PRNewswire/ — The American Pharmacists Association released the following statement after Congress’s response…
Read MoreShare this Story AdaniConneX is well-positioned to lead India’s data center market expansion, combining speed, reliability, and scalability along with…
Read MoreShare this Story Exclusive Christmas Package Offer Starting from $499 For Two to $699 For Three HONG KONG, Dec. 17,…
Read MoreShare this Story Advanced Snail Mucin Glass Glow Hydrogel Mask Takes #1 Spot in Beauty and Personal Care NEW YORK,…
Read MoreShare this Story SINGAPORE, Dec. 17, 2024 /PRNewswire/ — Gravity Game Hub (GGH) PTE.LTD, a subsidiary of GRAVITY Co., Ltd.…
Read MoreShare this Story NEW YORK, Dec. 17, 2024 /PRNewswire/ — Report with the AI impact on market trends – The…
Read MoreShare this Story BEIJING, Dec. 17, 2024 /PRNewswire/ — A report from China Daily Enterprises in Wuhan city, Central China’s…
Read More